Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review
There is increasing interest in the concept of ‘treat-to-target’ in inflammatory bowel disease as a mechanism to standardize management and prevent complications. While clinical, radiographic and endoscopic treatment end points will figure prominently in this promising management paradigm, the role...
Saved in:
| Main Authors: | Travis B Murdoch, Sarah O’Donnell, Mark S Silverberg, Remo Panaccione |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2015/389548 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Validation of an Administrative Case Definition for Inflammatory Bowel Diseases
by: Ali Rezaie, et al.
Published: (2012-01-01) -
Environment and the Inflammatory Bowel Diseases
by: Alexandra Frolkis, et al.
Published: (2013-01-01) -
Canadian Association of Gastroenterology Position Statement Regarding the Use of Thiopurines for the Treatment of Inflammatory Bowel Disease
by: John K Marshall, et al.
Published: (2014-01-01) -
Genetics of Inflammatory Bowel Disease: Current Status and Future Directions
by: Thomas D Walters, et al.
Published: (2006-01-01) -
Infliximab for the Treatment of Crohn'S Disease: Review and Indications for Clinical Use in Canada
by: Remo Panaccione
Published: (2001-01-01)